突变对MUC1-C/ED蛋白稳定性和抗体结合的影响:结构洞察力
Dwipanjan Sanyal1, Danny Muzata2, Vladimir N Uversky3
1XYone Therapeutics, Canton, MA, USA.
Biochemical and biophysical research communications
|June 11, 2025
概括
了解MUC1抗原突变是抗体-药物联合 (ADC) 癌症治疗的关键. 特定的MUC1突变影响抗体结合,影响ADC的有效性和稳定性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 抗体-药物合物 (ADC) 是一种有前途的癌症治疗方法,利用单克隆抗体进行向药物输送.
- MUC1是一种型蛋白和ADC发展的基抗原,3D1抗体特别结合其MUC1-C细胞外域.
- 包括MUC1-C在内的MUC1 SEA域对抗体相互作用至关重要.
研究的目的:
- 研究特定点突变 (D85E,V86A,T88A) 在MUC1 SEA域对3D1抗体结合亲和力和抗原稳定性的影响.
- 阐明这些MUC1突变引起的改变结合动态的基础分子机制.
主要方法:
- 使用计算方法分析形状变化和结合亲和力.
- 检查MUC1-C和3D1抗体界面上的静电,键和疏水相互作用.
- 计算局部丧和能量,以评估蛋白质稳定性.
主要成果:
- 突变D85E和T88A通过改变静电和结合相互作用,诱导了显著的形状变化和降低了结合亲和力.
- 突变V86A破坏了局部疏水性相互作用,降低了结合效率,同时保持了整体形状.
- 这三种突变 (D85E,V86A,T88A) 都增加了局部能量和丧,表明MUC1 SEA域稳定性降低.
- MUC1的α3螺旋被确定为蛋白质稳定性和抗体相互作用的关键.
结论:
- 在MUC1 SEA域内的特定残留物对于维持有效的3D1抗体结合至关重要,因为它们有助于局部丧和稳定.
- 这些关键残留物的突变可以显著改变抗原结合动态,影响ADC的治疗潜力.
- 了解这些残留物特定相互作用对于设计和优化MUC1向的ADCs至关重要.
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Mutations
81.0K
Overview
81.0K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K


